Actavis, Inc. News Headlines

ACT 
$291.36
*  
1.58
0.55%
Get ACT Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Actavis Earnings Soar as Closing of Allergan Deal Looms -- Update
2/18/2015 8:00:00 AM - Dow Jones Business News


MARKET SNAPSHOT: U.S. Stocks: Futures Search For Direction Ahead Of FOMC Minutes
2/18/2015 7:54:00 AM - Dow Jones Business News


Actavis Earnings Soar as Closing of Allergan Deal Looms
2/18/2015 7:17:00 AM - Dow Jones Business News


Actavis Plans To Adopt "Allergan" Corporate Name - Quick Facts
2/18/2015 7:09:00 AM - RTT News


Actavis Outlines Standalone Pharma Pipeline - Quick Facts
2/18/2015 7:01:00 AM - RTT News


Actavis Q4 Profit Tops Estimates - Quick Facts
2/18/2015 6:52:00 AM - RTT News


Eagle Soars, VBLT Crushed Over Drug Failure, Study Fails To Soothe CLTX
2/18/2015 2:07:00 AM - RTT News


How to Trade Activis Ahead of Its Earnings Report: Time to Take Profits
2/17/2015 3:37:00 PM - TheStreet


Pharmaceuticals - Is Organic Growth No Longer Enough?
2/17/2015 9:13:00 AM - Seeking Alpha


Tracking Dan Loeb's Third Point Portfolio - Q4 2014 Update
2/17/2015 3:24:00 AM - Seeking Alpha


Gameplan For The Coming Week - Cramer's Mad Money (2/13/15)
2/16/2015 7:43:00 AM - Seeking Alpha


The Best Stocks To Buy This Week
2/15/2015 2:02:00 PM - Seeking Alpha


Jim Cramer's Top Stock Picks: ACT PCLN CLX HAIN WWAV NVAX
2/14/2015 6:00:00 AM - TheStreet


Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
2/13/2015 4:00:00 PM - Seeking Alpha


Actavis To Sell Pharmatech To TPG - Quick Facts
2/13/2015 8:38:00 AM - RTT News


Brookdale Senior Living: The largest senior living operator
2/12/2015 1:26:00 PM - Market Realist


Don't Discount Bill Ackman
2/11/2015 12:13:00 PM - Seeking Alpha


CVRs - The Good, The Bad And The Ugly
2/11/2015 1:40:00 AM - Seeking Alpha


Wall Street Stocks Head Towards Cautious Start
2/10/2015 6:41:00 AM - RTT News


Actavis to Divest U.S. Doryx Rights Before Allergan Deal
2/9/2015 7:55:00 PM - Dow Jones Business News


Actavis to Divest Itself of U.S. Doryx Rights Ahead of Allergan Deal -- Update
2/9/2015 6:57:00 PM - Dow Jones Business News


AstraZeneca Might Need More Than Buzzwords To Bridge The Gap
2/9/2015 2:57:00 PM - Seeking Alpha


Millennium Management increases position in American Express
2/6/2015 3:05:00 PM - Market Realist


Millennium Management increases position in Actavis
2/6/2015 12:05:00 PM - Market Realist


Zogenix Approval Sheds Light On Path For Elite Pharmaceuticals
2/6/2015 8:00:00 AM - Seeking Alpha